BRAF Mutations and Expression of Anti-BRAF-V600E (VE1) in Low-grade Serous Tumors of the Ovary

被引：0
|
作者：
Turashvili, Gulisa [1 ]
Grisham, Rachel [1 ]
Chiang, Sarah [1 ]
DeLair, Deborah [1 ]
Park, Kay [1 ]
Soslow, Robert [2 ]
Murali, Rajmohan [1 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
[2] MSKCC, New York, NY USA
来源：
LABORATORY INVESTIGATION | 2018年 / 98卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
1298
引用
收藏
页码：459 / 459
页数：1
相关论文
共 50 条
  • [31] Immunohistochemical detection of the BRAF V600E mutation in melanoma patients with monoclonal antibody VE1
    Liu, Hui
    Li, Zhongwu
    Wang, Yan
    Feng, Qin
    Si, Lu
    Cui, Chuanliang
    Guo, Jun
    Xue, Weicheng
    PATHOLOGY INTERNATIONAL, 2014, 64 (12) : 601 - 606
  • [32] A UK feasibility and validation study of the VE1 monoclonal antibody immunohistochemistry stain for BRAF-V600E mutations in metastatic melanoma
    Lo, Michelle Chin I.
    Paterson, Anna
    Maraka, Jane
    Clark, Richard
    Goodwill, Joseph
    Nobes, Jenny
    Garioch, Jennifer
    Moncrieff, Marc
    Rytina, Ed
    Igali, Laszlo
    BRITISH JOURNAL OF CANCER, 2016, 115 (02) : 223 - 227
  • [33] Mutations in low-grade serous ovarian cancer and response to BRAF and MEK inhibitors
    Moujaber, Tania
    Etemadmoghadam, Dariush
    Mapagu, Cristina
    Kennedy, Catherine
    Chiew, Yoke-Eng
    Kan, Casina
    Nevins, Nikilyn
    Srirangan, Sivatharsny
    Fereday, Sian
    Traficante, Nadia
    Bowtell, David
    Balleine, Rosemary
    Harnett, Paul
    deFazio, Anna
    CANCER RESEARCH, 2018, 78 (13)
  • [34] In ovarian neoplasms, BRAF, but not KRAS, mutations are restricted to low-grade serous tumours
    Sieben, NLG
    Macropoulos, P
    Roemen, GM
    Kolkman-Uljee, SM
    Fleuren, GJ
    Houmadi, R
    Diss, T
    Warren, B
    Al Adnani, M
    de Goeij, AP
    Krausz, T
    Flanagan, AM
    JOURNAL OF PATHOLOGY, 2004, 202 (03): : 336 - 340
  • [35] Mutations in BRAF and KRAS characterize the development of low-grade ovarian serous carcinoma
    Singer, G
    Oldt, R
    Cohen, Y
    Wang, BG
    Sidransky, D
    Kurman, RJ
    Shih, IM
    MODERN PATHOLOGY, 2003, 16 (01) : 211A - 211A
  • [36] Mutations in BRAF and KRAS characterize the development of low-grade ovarian serous carcinoma
    Singer, G
    Oldt, R
    Cohen, Y
    Wang, BG
    Sidransky, D
    Kurman, RJ
    Shih, IM
    LABORATORY INVESTIGATION, 2003, 83 (01) : 211A - 211A
  • [37] A case of an epithelioid glioblastoma with the BRAF V600E mutation colocalized with BRAF intact low-grade diffuse astrocytoma
    Kuroda, Jun-Ichiro
    Nobusawa, Sumihito
    Nakamura, Hideo
    Yokoo, Hideaki
    Ueda, Ryuta
    Makino, Keishi
    Yano, Shigetoshi
    Kuratsu, Jun-ichi
    NEUROPATHOLOGY, 2016, 36 (02) : 181 - 186
  • [38] BRAF VE1抗体在结直肠癌中检测BRAF V600E突变的应用
    时姗姗
    王璇
    夏秋媛
    陆珍凤
    叶胜兵
    杨万瑞
    马恒辉
    饶秋
    周晓军
    临床与实验病理学杂志, 2016, 32 (12) : 1383 - 1385
  • [39] Mutations in BRAF and KRAS characterize the development of low-grade ovarian serous carcinoma
    Singer, G
    Oldt, R
    Cohen, Y
    Wang, BG
    Sidransky, D
    Kurman, RJ
    Shih, IM
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2003, 95 (06) : 484 - 486
  • [40] A UK feasibility and validation study of the VE1 monoclonal antibody immunohistochemistry stain for BRAF-V600E mutations in metastatic melanoma
    Michelle Chin I Lo
    Anna Paterson
    Jane Maraka
    Richard Clark
    Joseph Goodwill
    Jenny Nobes
    Jennifer Garioch
    Marc Moncrieff
    Ed Rytina
    Laszlo Igali
    British Journal of Cancer, 2016, 115 : 223 - 227
12345